Singular Genomics News

Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $0.85

BenzingaJan 23 22:20

Singular Genomics Sys Analyst Ratings

BenzingaJan 23 22:19

Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $0.85

BenzingaJan 22 20:50

Singular Genomics Sys Analyst Ratings

BenzingaJan 22 20:46

Hold Rating on Singular Genomics Systems (OMIC) Amid Q3 Underperformance and Strategy Shift

TipRanksNov 16, 2023 14:55

UBS Adjusts Singular Genomics Systems Price Target to $0.40 From $0.90, Maintains Neutral Rating

MT NewswiresOct 12, 2023 23:28

Singular Genomics Sys Analyst Ratings

BenzingaAug 10, 2023 21:34

UBS Adjusts Singular Genomics Systems Price Target to $1.25 From $2.25, Maintains Neutral Rating

MT NewswiresMay 10, 2023 22:11

UBS Adjusts Singular Genomics Systems Price Target to $2.25 From $2.50, Maintains Neutral Rating

MT NewswiresMar 7, 2023 01:31

Goldman Sachs Adjusts Price Target on Singular Genomics Systems to $3 From $3.50, Maintains Neutral Rating

MT NewswiresNov 8, 2022 23:35

Singular Genomics Sys Analyst Ratings

Benzinga Analyst RatingsNov 8, 2022 21:32

Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $3

Benzinga Real-time NewsNov 8, 2022 21:31